Jennifer E. Fairman, CMI, FAMI

Certified Medical Illustrator | Associate Prof JHUSOM Entrepreneur, Science Story-teller; all words = mine,

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

See you on bluesky https://t.co/ni4lSXnlI2

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

See you on bluesky https://t.co/ni4lSXnlI2

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

We love our weird jobs! Great interview with fellow medical illustrator @Vin_the_human Vinald Francis on NPR: https://t.co/s6Wz7SDNx1 #weirdjob #medicalIllustrator

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

The damage from Hurricane Helene is heartbreaking. A good friend’s local shop has been destroyed, leaving workers without jobs. Please consider donating or sharing to help rebuild. Every bit counts. https://t.co/sB1oZYICIX

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

I just backed Periodical and Annual Cicada Enamel Pins on @Kickstarter https://t.co/rvspuGb8IE

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

So excited to join The Generative AI Growth Mindset's course. Looking for a few friends to join me! https://t.co/zNU4lE3MeO

[Elsa Anagnostou @ValsamoA]

Checkout our new @MolecularOncLab website!
https://t.co/geJi9rsnxl
We are looking for new wet lab members to join our multi-omics and liquid biopsy efforts (research tech and post-doc level -the latter for folks with a PhD in cancer biology-), contact us if there is interest!

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

Another great collaboration and the featured cover with @Rock1MD Reyhan Westbrook, Mariann Gabrawy, @JeremyWalstonMD et. al. #kynurenine #NAD #frailty #geriatricmedicine https://t.co/zUZHiRzkPA

[TimePie (focus on anti-aging science) @TimePieChina]

#OpenAccess
Dual treatment with #kynurenine pathway inhibitors and #NAD+ precursors synergistically extends #life span in Drosophila 🪰🌟🔬

Applause to @ Mariann M. Gabrawy @ Reyhan Westbrook @JeremyWalstonMD @Rock1MD et al. 👏
https://t.co/gcNmE65iMj

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

Exciting news of the week - just received my print copies of my latest journal cover! For Diabetes (journal for the ADA) Dax Fu, et. al.
@JohnsHopkins
@JhuMedart
#molecularvisualization #sciart https://t.co/oIGQiflAlg

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

Jung’s Five Pillars of a Good Life - The Atlantic. I just love this! https://t.co/wIYz3n7Tkr

[Geoff Faulkner @Faulkner_Lab]

My pick for "the" mobile DNA paper of 2023 is actually two studies published back-to-back @Nature reporting the long-sought structure of L1 ORF2p _and_ fundamental insights into the mechanism by which L1 jumps. Amazing work. 1/n

https://t.co/1Woxda7Kfh

https://t.co/1Woxda7Kfh

[Marty Taylor, MD PhD @DrMartyTaylor]

https://t.co/2NUeefEIZX
Really cool video on LINE-1 and our work on ultrasensitive detection of Orf1p. I love their description of the total lack of creativity in naming the LINE-1 proteins. Orf1=“Protein McProtein Face”.

https://t.co/ucfZvlhiI1

[Mass General Brigham Research @MGBResearchNews]

Researchers from @MGHPathology and colleagues discover that structural analysis and inhibition of human LINE-1 ORF2 protein reveals novel adaptations and functions, in a @nature study. https://t.co/jc53O1yzk5

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

@DrMartyTaylor 👏🏻👏🏻👏🏻👏🏻

[Jennifer E. Fairman, CMI, FAMI @fairmanstudios]

Totally excited to see this! Go, Marty go!

[Marty Taylor, MD PhD @DrMartyTaylor]

Excited for the poster session at #SU2CScienceSummit and to share our work on the LINE-1 transposon and its role in cancer diagnostics and mechanisms.

[Marty Taylor, MD PhD @DrMartyTaylor]

@MGH_RI Link to the paper 👇https://t.co/EJOdCq2RzZ

[Mass General Brigham Research @MGBResearchNews]

Did you know that a significant portion of our genetic code, once dismissed as “junk DNA,” might hold a key to understanding diseases?

Scientists have uncovered what could be a game-changer in our understanding of health and disease:
https://t.co/tZvm8XNrSK

[Trevor Van Eeuwen @_themovingvan_]

Using single particle cryo-EM, we determined three structures in different functional states. Apo ORF2p is in an active “thumb up” state; in contrast, apo viral RTs adopt an inactive “thumb down” state. This may explain ‘cis preference’: L1’s penchant for binding its own RNA

[Trevor Van Eeuwen @_themovingvan_]

We purified ORF2p ‘core’ and determined of a 2.1 angstrom crystal structure, facilitating discovery of two novel domains we name the ‘tower’ and ‘wrist’. These flank the fingers-palm-thumb domains of reverse transcriptase (RT), which grip the nucleic acid like a “right hand”